A tool to guide safe opioid dose reduction
Part of Mental health clinical trials.
This study tests a computer tool that helps doctors and patients safely reduce opioid pain medication. If you are tapering your opioid dose, the tool may help make the process smoother and safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a primary care patient currently in the process of having your opioid dose reduced (tapered).
- You need to have been taking a prescription opioid for more than three months.
- You must meet at least one of: a high daily dose (more than 90 MME), taking a benzodiazepine along with your opioid, or having your dose reduced by more than 5% recently.
- You must be between the ages of 12 and 89.
- You cannot have had an active cancer diagnosis in the last year.
- You cannot be in hospice or palliative care, and you cannot have sickle cell disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a tool that helps doctors decide when it's safe to adjust opioid prescriptions for patients. It aims to prevent risks when switching between short-term, longer-term, and ongoing opioid use.
This trial tests if a computer tool can help doctors prescribe medications for opioid use disorder during regular checkups. It may be right for you if you take prescription opioids for pain or have had issues with opioids.
This Phase 2 study looks at what opioid withdrawal looks like in the body and whether they can measure it in a meaningful way. You may join if you have an opioid use disorder, can show physical dependence, and are interested in tapering (gradually reducing) opioids under study care.
This study tests a digital tool called Compl-AI that aims to predict whether someone with opioid use disorder might stop their medication early. If it works, doctors could step in sooner to help people stay on treatment.
This study tests a new way to help people in the emergency department who have moderate to severe opioid use disorder. It looks at using a decision-support tool to guide treatment choices.
This trial is testing a tool to help people in the emergency department decide whether to start buprenorphine (a medication for opioid use disorder). It's for patients who are not already on medication for their condition.
Hear when a new Medication Abuse trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.